Navigation Links
SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012
Date:2/16/2012

BOTHELL, Wash., Feb. 16, 2012 /PRNewswire/ -- SCOLR Pharma, Inc. (OTCQB: SCLR) announced today that it has launched several new extended-release nutritional/vitamin products based on the Company's patented oral drug delivery platform, Controlled Delivery Technology (CDT®). Eleven class-leading products are now being sold under various private label brands across the country at the nation's top retail chains. 

Each product has been designed to deliver the full nutritional or vitamin dosage over a period of time from 12 to 24 hours.  The products are available on the vitamin/nutritional supplement aisles and are easily identifiable by their 12 or 24 Hour package logo and/or Extended Release or Controlled Release nomenclature.

The Company's flagship extended release formulations are Niacin 500mg 12HR Controlled-Release, Vitamin C 1000 mg 12HR, CoQ-10 100 mg 24HR, Glucosamine Chondroitin MSM Advanced 12HR Combo, and three 24HR calcium formulations; Calcium 1200 +D with calcium citrate, Calcium + Vitamin D Plus Minerals, and Calcium + Vitamins D & K.

The Company has plans later this year to launch several new nutritional/vitamin products under its house brand SCOLR® and for additional private label products with new and existing retailers.

Stephen J. Turner, SCOLR Pharma's President and CEO, said, "This is an exciting and landmark step for SCOLR.  The acceptance by so many retailers of our nutritional products indicates there is a strong consumer demand for extended release nutritional products and vitamins. We are very enthused about the business opportunity this represents for SCOLR and our patented technologies. "

About SCOLR Pharma:
Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and n
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SCOLR Pharmas Partner to Commence Bioequivalence Study of Ondansetron
2. SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products
3. SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results
4. SCOLR Pharma, Inc. First Quarter 2011 Financial Results
5. SCOLR Pharma, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference
6. SCOLR Pharma, Inc. Reports 2010 Financial Results, Provides Updates on Advances in Nutritionals, OTC Drugs
7. SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
8. SCOLR Pharma, Inc. Retains Nicholas Hall & Company
9. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
10. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
11. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... UT Southwestern Medical Center President Dr. ... U.S. Representatives Michael C. Burgess , M.D., and ... the 21 st Century Cures Act, bipartisan legislation ... the United States Senate. ... Sciences members, department chairs, center directors, and leading researchers ...
(Date:9/1/2015)... RIVER, Mass. , Sept. 1, 2015   ... an additional 120,000 square feet in Olive Branch, ... Olive Branch facility has added the ... warehousing space. "This expansion gives us the ... Karl Neuberger , President of Millstone MS. "Two and a ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015 ... Care Management (CCM) and Drug Adherence m Health ... help automate the process of non face-to-face monitoring ... "With this new release of our apps, doctors ... management services along with our ONCHIT certified Physician, ...
Breaking Medicine Technology:U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 4U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 5Millstone Medical Outsourcing Announces Olive Branch Expansion 2SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2
... Feb. 8, 2012  MiMedx Group, Inc. (OTCBB: MDXG), ... protected regenerative biomaterials and bioimplants processed from human ... Injectable, the Company,s newest tissue offering. MiMedx is ... day of the American Academy of Orthopaedic Surgeons ...
... ALISO VIEJO, Calif., Feb. 8, 2012 Avanir ... today that the results of the study entitled "Efficacy ... for Diabetic Neuropathic Pain: A Double-Blind, Placebo-Controlled, Multicenter Study" ... journal Pain Medicine. "Throughout a 13-week ...
Cached Medicine Technology:MiMedx Announces Nationwide Launch of AmnioFix® Injectable at American Academy of Orthopaedic Surgeons Annual Meeting 2MiMedx Announces Nationwide Launch of AmnioFix® Injectable at American Academy of Orthopaedic Surgeons Annual Meeting 3MiMedx Announces Nationwide Launch of AmnioFix® Injectable at American Academy of Orthopaedic Surgeons Annual Meeting 4Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain 2Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain 3Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain 4
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 article ... surgeries conducted each year on teenagers, quoting a New York City-area plastic surgeon ... plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to patients and ...
(Date:9/1/2015)... ... 01, 2015 , ... The Capillus82™ has been cleared by ... in adults, announces Miami-based medical device manufacturer, Capillus, LLC. FDA clearance substantiates the ... when used at home to combat hair loss. , “Following the success ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... therapy company, is pleased to announce their partnership with Apex Physical Therapy ... both groups to continue to provide kind, compassionate, and empathetic care to local ...
(Date:9/1/2015)... NY (PRWEB) , ... September 01, 2015 , ... From ... 86 children and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at ... staff included 65 adult counselors, some of whom work for Calvary, and two junior ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... cure and prevent different malignancies. Some options for cancer treatment are available ... to which distinctive approach is necessary for effective treatment. Several molecules have ...
Breaking Medicine News(10 mins):Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3
... ... health testing stations and automated blood pressure monitors, is exhibiting its LC500 Health Station ... Well Being at the 2009 AARP Vegas@50+ National Event and Expo. , ... Burtonsville, MD (PRWEB) October 19, ...
... bears further study, researchers say , MONDAY, Oct. 19 ... treat inflammatory bowel disease (IBD) increases the risk of ... study. , IBD includes Crohn,s disease and ulcerative colitis. ... in order to maintain remission in IBD patients. , ...
... ... Inc., today announced that the U.S. Food and Drug Administration (FDA) ... monoclonal antibodies in its proprietary line of transfusion diagnostics. These ... hospitals to type and screen blood. Quotient Biodiagnostics was formed earlier ...
... 19 According to Google Trends ( www.google.com/trends/hottrends?q=the+cookie+diet&date=2009-10-16&sa=X ... ranking of the 40 most-searched terms on the Google ... sixth most-searched term last Friday. The highest ranking term ... boy throws up" which ranked a distant fifteenth. ...
... of Kansas City, serving residents of Kansas City and beyond ... a separate section on Cosmetic Surgery for Males, a new ... breaking news on emerging research, techniques and products. , According ... for males increased by 17 per cent last year, with ...
... , EVANSVILLE, Ind., Oct. 19 In the first year ... lifelong growth, health and well-being. And for the first time, ... how nutrition plays a vital role in babies, health, growth ... available online. , To view the Multimedia News Release, go ...
Cached Medicine News:Health News:Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 2Health News:Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 3Health News:Drugs for Irritable Bowel Might Increase Cancer Risk 2Health News:Quotient Biodiagnostics Receives U.S. Food & Drug Administration Clearance to Enter U.S. Transfusion Diagnostics Market 2Health News:Quotient Biodiagnostics Receives U.S. Food & Drug Administration Clearance to Enter U.S. Transfusion Diagnostics Market 3Health News:Dr. Siegal's Cookie Diet Beats 'Balloon Boy' Story on Google's Most-Searched Topics List 2Health News:Dr. Siegal's Cookie Diet Beats 'Balloon Boy' Story on Google's Most-Searched Topics List 3Health News:Premier Plastic Surgery of Kansas City's Extended Website Provides Latest Information on Male and Female Cosmetic Surgery 2Health News:Premier Plastic Surgery of Kansas City's Extended Website Provides Latest Information on Male and Female Cosmetic Surgery 3Health News:Premier Plastic Surgery of Kansas City's Extended Website Provides Latest Information on Male and Female Cosmetic Surgery 4Health News:Photos: First-of-Its-Kind Website Unveiled at 'Modern Moms Meet Modern Science' Meeting 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: